| PACAX | PACYX | PACAX / PACYX | |
| Total Expense Ratio | 1.00 | 0.75 | 133% |
| Annual Report Gross Expense Ratio | 1.00 | 0.75 | 133% |
| Fund Existence | 32 years | 31 years | - |
| Gain YTD | 9.253 | 9.496 | 97% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 605M | 605M | 100% |
| Annual Yield % from dividends | 3.80 | 3.97 | 96% |
| Returns for 1 year | 8.54 | 8.78 | 97% |
| Returns for 3 years | 30.84 | 31.76 | 97% |
| Returns for 5 years | 10.15 | 11.55 | 88% |
| Returns for 10 years | 36.44 | 38.62 | 94% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| AMID | 34.30 | N/A | +0.01% |
| Argent Mid Cap ETF | |||
| FLYU | 58.49 | N/A | N/A |
| MicroSectors™ Travel 3X Leveraged ETNs | |||
| UCON | 25.17 | -0.01 | -0.04% |
| First Trust Smith Unconstrained Pl BdETF | |||
| DIAL | 18.48 | -0.03 | -0.16% |
| Columbia Diversified Fixed Inc Allc ETF | |||
| LFSC | 38.87 | -0.40 | -1.03% |
| F/m Emerald Life Sciences Innovation ETF | |||